Zdrowie i gospodarka · 10/07/2019

FDA Releases Final Guidance on Risk Evaluation and Mitigation Strategies (REMS) Modifications and Revisions

The Food and Drug Administration (FDA) has announced the availability of a final guidance document outlining procedures for submitting modifications and revisions to risk evaluation and mitigation strategies (REMS), which will help industry application holders navigate the regulatory process